Novateor Research Laboratories Share Price | Novateor Research Laboratories Stock Screener
NOVATEOR
Personal Care
Track Novateor Research Laboratories share price live with TickJournal's free stock screener.
Analyse Novateor Research Laboratories share price performance and track historical price performance.
Use the Novateor Research Laboratories stock screener below to analyse P/E ratio, market cap, quarterly results, and more. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Novateor Research Laboratories Market Cap
₹19.90 Cr.
NOVATEOR P/E Ratio (TTM)
-
Novateor Research Laboratories P/B Ratio
1.78
EPS (TTM)
₹0.17
Dividend Yield
-
Debt to Equity
0.11
NOVATEOR 52 Week High
-
Novateor Research Laboratories 52 Week Low
-
Operating Margin
-39.00%
Profit Margin
-
NOVATEOR Revenue (TTM)
-
EBITDA
-
Net Income
-
Total Assets
₹14.00
Total Equity
₹12.00
Novateor Research Laboratories Share Price Chart
Screen Novateor Research Laboratories share price with an interactive chart. Analyse NOVATEOR price trends and volatility across different timeframes.
Novateor Research Laboratories Company Profile - Fundamental Screener
Screen Novateor Research Laboratories company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for NOVATEOR shares.
Sector
Consumer Goods
Industry
Personal Care
Sub-Sector
Personal Care
Segment
E
ISIN
INE08JY01013
Novateor Research Laboratories Balance Sheet Screener
Screen NOVATEOR balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Total Assets | 14 | 13 | 11 | 9 | 8 | 9 | 9 | 4 | 2 | 2 |
| Current Assets | 11 | 9 | 8 | 7 | 6 | 6 | 5 | 1 | 0 | 0 |
| Fixed Assets | 3 | 3 | 2 | 2 | 2 | 3 | 4 | 4 | 2 | 2 |
| Liabilities | ||||||||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 1 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||||
| Total Equity | 12 | 11 | 9 | 8 | 8 | 9 | 9 | 4 | 1 | 1 |
| Share Capital | 6 | 5 | 5 | 5 | 5 | 5 | 5 | 3 | 0 | 0 |
| Reserves & Surplus | 5 | 3 | 4 | 3 | 3 | 4 | 4 | 1 | 1 | 1 |
Novateor Research Laboratories Income Statement Screener - Profit & Revenue Analysis
Screen Novateor Research Laboratories income statement and profit fundamentals.
Analyze NOVATEOR quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Novateor Research Laboratories share price evaluation.
| Item | None-None | 2026-March | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March | 2015-March |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 4 | 3 | 2 | 2 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 |
| Expenses | 0 | 4 | 3 | 2 | 2 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
| EBITDA | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Profit % | -39.00% | -3.00% | -5.00% | -27.00% | -28.00% | -25.00% | -176.00% | -35.00% | 71.00% | 59.00% | 42.00% | -6.00% | 2.00% |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Profit | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS | 0.00 | 0.17 | 0.17 | 0.06 | 0.08 | -0.47 | 0.02 | -0.02 | 0.74 | 0.18 | -0.62 | 0.05 | 0.30 |
Novateor Research Laboratories Cash Flow Screener - Liquidity Fundamentals
Screen NOVATEOR cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | -1 | -1 | -1 | -1 | 0 | -3 | 0 | 0 | 0 | 0 |
| Investing Activities | 0 | 0 | 0 | 1 | 0 | 0 | -2 | 0 | 0 | 0 |
| Financing Activities | 1 | 1 | 1 | 0 | 0 | 4 | 2 | 0 | 0 | 0 |
| Net Cash Flow | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 |
Novateor Research Laboratories Shareholding Pattern Screener
See Novateor Research Laboratories shareholding pattern with promoter, FII, and DII holdings.
Check Novateor Research Laboratories promoter holding and ownership changes for NOVATEOR on TickJournal.
| Item | 2026-Mar | 2025-Mar | 2025-Sept | 2024-Mar | 2024-Sept | 2023-Mar | 2023-Sept | 2022-Mar |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 50.75% | 51.60% | 50.90% | 60.87% | 60.87% | 60.87% | 60.87% | 60.87% |
| FII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| DII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 30.00% | 29.11% | 29.90% | 27.14% | 26.52% | 26.52% | 26.89% | 30.86% |
| Other Holding | 19.24% | 19.29% | 19.19% | 11.99% | 12.61% | 12.61% | 12.24% | 8.27% |
| Shareholder Count | 172 | 164 | 172 | 122 | 160 | 113 | 118 | 138 |
Novateor Research Laboratories Share Dividend Screener - Share Yield Analysis
Check Novateor Research Laboratories dividend history with payout and yield data.
View Novateor Research Laboratories dividend details including ex-dates and amounts for NOVATEOR stock.
Novateor Research Laboratories Stock Index Membership
See which indices include Novateor Research Laboratories stock.
Check NOVATEOR index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
Novateor Research Laboratories Market Events Screener - Corporate Actions
Get Novateor Research Laboratories corporate actions including splits, bonuses, and buybacks.
Check Novateor Research Laboratories stock events that may affect NOVATEOR share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| Annual General Meeting | NA | -22.17% | ||
| Annual General Meeting | NA | -1.82% | ||
| 2026-05-30 | 2026-05-30 | Quarterly Result Announcement | NA | 0.00% |
| 2025-11-14 | 2025-11-14 | Quarterly Result Announcement | NA | 0.00% |
| 2025-05-30 | 2025-05-30 | Quarterly Result Announcement | NA | 0.00% |
| 2024-11-14 | 2024-11-14 | Quarterly Result Announcement | NA | -2.01% |
| 2024-07-20 | 2024-07-20 | Extraordinary General Meeting | NA | 8.57% |
| 2023-12-03 | 2023-12-03 | Extraordinary General Meeting | NA | -11.67% |
Novateor Research Laboratories Competitors Screener - Peer Comparison
Screen NOVATEOR competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Godrej Consumer Products | 103,348 | 56.15 | 15,100 | 2.86% | 1,985 | 45.49 |
| Dabur India | 74,896 | 40.47 | 13,193 | 0.61% | 1,883 | 41.87 |
| Colgate Palmolive | 54,340 | 41.02 | 5,984 | -3.16% | 1,316 | 43.70 |
| P&G Hygiene and Health Care | 29,487 | 33.37 | 4,282 | 25.49% | 863 | 44.66 |
| Cupid | 25,539 | 235.38 | 358 | 76.04% | 110 | 88.67 |
| Gillette | 25,024 | 37.65 | 3,100 | 36.98% | 648 | 45.01 |
| Emami | 17,648 | 23.00 | 3,780 | -2.52% | 757 | 49.45 |
| Mamaearth | 14,929 | 72.69 | 2,392 | 11.48% | 197 | 76.86 |
| Bajaj Consumer Care | 7,824 | 41.06 | 1,153 | 15.30% | 190 | 58.09 |
| Anondita Medicare | 2,078 | 61.51 | 137 | 78.24% | 36 | 51.55 |
Novateor Research Laboratories Company Announcements - News Screener
Screen NOVATEOR latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-06-15 | Launch Of New Product- Smiloshine Herbafresh Toothpaste Formulated With 8 Herbs 6 Grams Sachet | - |
| 2026-05-30 | Board Meeting Outcome for Approval And Adoption Of Audited Financial Results For The Half Year And Year Ended On March 31 2026 | - |
| 2026-05-26 | Board Meeting Intimation for Adoption Of Audited Financial Results For The Half Year And Year Ended On March 31 2026 | - |
| 2026-04-30 | Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2 | - |
| 2026-04-30 | Launch Of New Product- Smiloshine Herbafresh Toothpaste | - |
| 2026-04-07 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2026-03-31 | Closure of Trading Window | - |
| 2026-02-11 | Launch Of New Product- Smiloshine Aligner And Denture Cleaner And Whitener Foam | - |
| 2026-01-16 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2025-11-14 | Unaudited Financial Results For The Half Year Ended On 30.09.2025 | - |
| 2025-11-14 | Board Meeting Outcome for Unaudited Financial Results For The Half Year Ended On September 30 2025 | - |
| 2025-11-08 | Board Meeting Intimation for Adoption Of Financial Results For The Half Year Ended On September 30 2025 | - |
| 2025-11-03 | Appointment of Company Secretary and Compliance Officer | - |
| 2025-10-06 | Non Applicability Of Submission Of Related Party Disclosures For The Half Year Ended On September 30 2025 | - |
| 2025-10-06 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2025-09-30 | Announcement under Regulation 30 (LODR)-Amendments to Memorandum & Articles of Association | - |
| 2025-09-30 | Announcement under Regulation 30 (LODR)-Change in Directorate | - |
| 2025-09-30 | Shareholder Meeting / Postal Ballot-Outcome of AGM | - |
| 2025-09-30 | Closure of Trading Window | - |
| 2025-09-17 | Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 | - |